Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07784296 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension

Study acronym: AMPR-OS-2503
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
A multicenter, prospective, non-interventional, observational study to evaluate effectiveness and safety of sequential triple combination therapy (amlodipine/losartan/chlorthalidone) in Korean patients with hypertension
Trial Details
NCT Number NCT07784296
Lead Sponsor Hanmi Pharmaceutical Company Limited
Conditions
(from sponsor)		 Hypertension
Related terms Hypertension
Enrollment 3,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov